GÜNAY, S.; PARLAK, I. S.; HEZER, H.; ŞEREF PARLAK, E. Şengül; UMUT, M. S.; HANCIOĞLU, Z.; ÇELENK ERGÜDEN, H.; KOCAMAN, Y.; DALKIRAN, A.; SERTÇELIK, Ümran; ŞERIFOĞLU, İrem; AKPINAR, E.; GÖKTAŞ, M. F.; FIDAN, M.; BABAHANOĞLU, B.; CANDER, F. S.; ÇIVGIN, E.; ER, M.; KILIÇ, H.; ARGÜDER, E.; TUĞ, T.; ÜNSAL, E.; HASANOĞLU, C.; GÜNAY, İrem; BABAYIĞIT, M. .; AĞCA, B.; KARALEZLI, A. Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up: Interstitial lung disease following severe COVID-19 pneumonia. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, [S. l.], v. 40, n. 3, p. e2023029, 2023. DOI: 10.36141/svdld.v40i3.14418. Disponível em: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/14418. Acesso em: 5 dec. 2023.